Transcript THE EMCDDA AND THE REITOX NETWORK

The EMCDDA and the Reitox network:
towards quality achievement
Sandrine Sleiman, Scientific Committee, Palmela, February 2008
Contents
• National focal points (NFP)
• Operating framework
• Challenges
What is a NFP?
An information interface between the Member State and the
EMCDDA. The NFPs play a double role:
• ‘National authority’ for providing national drug
information to
the EMCDDA (under national responsibility)
• ‘Ambassador’ of the EMCDDA at national level
(under EMCDDA guidance)
Role of Reitox
Mechanism for collecting and exchanging
information between the EMCDDA and 30
countries:
• 27 EU Member States
• Norway
• 2 candidate countries
 European Commission
The REITOX Network
Austrian Health
Institute
Scientific Institute
Public Health
Institute for
Therapy
Research
University Mental
Health Research
Institute
Min. of Health
Drug Control
Department
Direction de la
Santé
Nat. Bureau
for Drug
Prevention
Nat. Monitoring
Centre for Drugs
and Drug Addiction
Estonian Drug
Monitoring
Centre
National
Commission for
Dependencies
Secretariat
Nat. Drug
Commission
Min. of Health
Nat. Centre for
Epidemiology
Trimbos Institute
Portuguese Institute Institute Public
Health
for Drugs & Drug
Addiction
National Board of
Health
Board of Ministers
for Drug
Dependencies
and Drug Control
French Observatory
for Drugs & Drug
Addiction
State Centre
Prevention & Rehabilitation Activities for Drug abuse
Prevention
Coordination Unit
Health Research
Board
SIRUS
National R&D Centre
for Welfare & Health
National Centre
for Addictions
European
Commission
Government Deleg. National Institute
to the National Plan of Public Health
on Drugs
Dept Min.
of Health
National AntiDrugs Agency
The future new members of EMCDDA
Turkey
TADOC – Turkish Academy against Drugs
and Organised Crime
Croatia
Office for Combating Narcotic Drug Abuse
And Western Balkan countries
Basis for Reitox cooperation with NFPs
•
Founding Council Regulation of the EMCDDA
•
Operating framework for the Reitox system
•
New reporting structure and tools
•
EMCDDA and Reitox work programmes
•
Grant agreements
•
Guidelines for reporting
How does a NFP work?
• Appointed by MS (national responsibility)
• Funded by MS, with EMCDDA co-financing
• Grant agreement for an action, 50% co-financing,
with max. 97.000 € per country (2007)
• Procedure for definition work programme
Working towards a high-quality NFP
- institutional challenges
•
Institutional framework
•
Legal base
•
Clear mandate (incl. national responsibilities)
•
Validity period of NFP nomination
•
National political support
•
Evidence-based decision-making with regard
to drugs and drug addiction
Working towards a high-quality NFP
- operational challenges
•
NFP competences should mirror the EMCDDA
subject areas
•
Cooperation with national/regional drug
information network(s) and scientific community
•
Interagency cooperation
•
Access to national and regional data
•
Human and financial resources
The new Reitox operating framework
• Result of a 2-y process: evaluation, working
group new operating framework, working
group new reporting tools
• Reporting tools
• Grant agreement
• Tasking process
• Capacity building
Guidelines for national reporting
Summary
Part A: New Developments and Trends
1. National policies and context
2. Drug Use in the Population
3. Prevention
4. Problem Drug Use
5. Drug-Related Treatment
6. Health Correlates and Consequences
7. Responses to Health Correlates and Consequences
8. Social Correlates and Consequences
9. Responses to Social Correlates and Consequences
10. Drug Markets
Part B – Selected Issues
11. Sentencing statistics
Part C
14. Bibliography
15. Annexes
Outputs of REITOX cooperation
Information collected and analysed at
national level and submitted to the EMCDDA
• National Reports, Structured Questionnaires, Standard
Tables
• Implementation of the epidemiological key indicators
• Data input into EMCDDA information systems
• Early warnings on new synthetic drugs to the EMCDDA
• Press clippings and replies to ad hoc requests
Reitox network challenges

Quality Assurance Policy
- Quality reports
- Implementation Needs Profiles

RTX Academy
- Motivating by supporting national needs
- Forging networking spirit
Process
Data consistency
Quality assessment
Quality check
Exploitation
Quality feedback
Since 2001 success…
• Generally recommendation for improvement
are applied regarding adherence to guidelines:
-
General layout
References to standard tables and structured questionnaires
Sources and use of Harvard for bibliography
Methodological information …
Efforts in writting the National report
Gaps to fill in…
• Respect of deadline
• Conciseness
• Weaknesses about lack of insight on trends
and interpretation of results …
• In some countries, it is still too early to have
many information on trends
2007 Reitox academies
• Reitox Academy on cannabis prevention and treatment
(29-30, March 2007)
• Reitox Academy on public expenditure analysis in the
field of drugs (May (TBC), Luxembourg)
• Reitox Academy Fonte training: introductory course
(22nd May, heads of NFP meeting, Lisbon)
• Reitox Academy Fonte training: specialised course
(8th, June, Ankara, Turkey)
•
Reitox Academy on science-based practices
(12-13 Sep, Oslo, Norway)
2008 and beyond
• RTX Academy on Media relations, TDI, analysis of
TDI data using different methodologies, qualitative
and quantitative and focus on data coverage.
• Towards further improvements of the academies:
• to link more regularly RTX Academies with Selected Issues
• to organise Academies for a broader audience (national
experts)
• to provide with additional features (MP3 files)
• updated strategy document on RTX Academy training
programme
To participate in the RTX network and to
face challenges, usefulness and added
values of the network should be perceived
at national level